medroxyprogesterone

(redirected from medroxyprogesterone acetate)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for medroxyprogesterone

a progestin compound (trade name Provera) used to treat menstrual disorders

Synonyms

References in periodicals archive ?
However, some patients request generic medroxyprogesterone acetate because it is so inexpensive (often $4 each month).
Gagne [10] reported significant improvement in hypersexual symptoms in 40/48 male sex offenders who were treated with medroxyprogesterone acetate and milieu therapy for 12 months.
5-mg medroxyprogesterone acetate group, one case in the placebo group, and none in the other groups.
Participants included 98 healthy female adolescents between the ages of 12 and 18 who initiated depot medroxyprogesterone acetate (DMPA) intramuscular injections for contraception and provided BMD data for up to 300 weeks after cessation of DMPA (Depo-Provera, Pfizer).
The girls were among 181 adolescents using depot medroxyprogesterone acetate (Depo-Provera, Pfizer) in a prospective study.
Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women [abstract].
Bone loss associated with the use of depot medroxyprogesterone acetate (DMPA), also known as Depo-Provera, occurred within two years of taking the birth control shot, especially in the hip and lower spine.
Researchers from the University of Birmingham treated 20 leukaemia patients too frail to undergo debilitating chemotherapy with the cholesterol-lowering drug Bezafibrate (BEZ) and the female contraceptive drug Medroxyprogesterone Acetate (MPA).
Scientists treated 20 acute myeloid leukaemia (AML) patients with cholesterol-lowering Bezafibrate and the female contraceptive drug Medroxyprogesterone Acetate and found that patients experienced none of the side effects associated with chemotherapy.
The regimens were: 20 mg medroxyprogesterone acetate (MPA) 3 times a day for 7 days followed by 20 mg daily for 3 weeks or an OC containing 35 mg ethinyl oestradiol plus 1 mg norethidrone 3 times a day for 7 days followed by 1 OC daily for 3 weeks.
Subcutaneous medroxyprogesterone acetate has been approved for the treatment of endometriosis-related pelvic pain.
It has approval of cefuroxime axetil tablets and medroxyprogesterone acetate prefilled syringes.
The second group of women had not had hysterectomies, and they received either the estrogens plus medroxyprogesterone acetate or placebo.
Here's the reality behind the WHI: Basically, in 2002 the WHI found that women taking the hormone therapy Prempro, composed of progestin (a synthetic progestogen known as medroxyprogesterone acetate or MPA) and conjugated equine estrogen, had a 26 percent increased risk of invasive breast cancer, a 29 percent increased risk of heart attack, a 41 percent higher rate of stroke and more than a 100 percent increase in blood clots in the lung.